Related Experiment Video

Updated: Aug 12, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Cancer drug discovery through collaboration

Christoph Lengauer1, Luis A Diaz, Saurabh Saha

  • 1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, Maryland 21231, USA. lengauer@jhmi.edu <lengauer@jhmi.edu>

Nature Reviews. Drug Discovery
|May 3, 2005
PubMed

Insights

Cancer

Area of Science:

  • Oncology and Genomics

Background:

  • Cancer's genetic basis was recognized two decades ago, promising early diagnosis and targeted treatments.
  • Despite advances, most cancer patients still lack effective life-saving therapies.
  • Tumor genetic uniqueness, revealed by '-omics' technologies, limits targeted therapy efficacy to small patient subgroups.

Purpose of the Study:

  • To address bottlenecks in anticancer drug discovery and development.
  • To explore collaborative strategies between academia, biotechnology, and pharmaceutical industries.

Main Methods:

  • Review of current challenges in cancer drug development.
  • Analysis of the impact of '-omics' technologies on cancer research.
  • Proposal for inter-sectoral collaboration.

Main Results:

  • Genomics reveals significant tumor heterogeneity, challenging broad therapeutic applications.
  • Current drug development pipelines face significant bottlenecks.
  • Collaboration can overcome limitations imposed by cancer's genetic complexity.

Conclusions:

  • Merging core competencies of academia, biotech, and pharma can accelerate anticancer drug discovery.
  • Addressing the complexity of cancer requires a coordinated, multi-disciplinary approach.
  • Overcoming drug development bottlenecks is crucial for delivering effective cancer treatments.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...